CMMB

Chemomab Therapeutics Ltd.

0.95 USD
-0.00 (-0.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Chemomab Therapeutics Ltd. stock is up 10.12% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 June’s closed higher than May.

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd. discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24.